Genpact Dividends and Buybacks
Dividend criteria checks 3/6
Genpact is a dividend paying company with a current yield of 2.18% that is well covered by earnings. Next payment date is on 25th June, 2026 with an ex-dividend date of 10th June, 2026.
Key information
2.2%
Dividend yield
4.6%
Buyback Yield
| Total Shareholder Yield | 6.8% |
| Future Dividend Yield | 2.4% |
| Dividend Growth | 13.8% |
| Next dividend pay date | 25 Jun 26 |
| Ex dividend date | 10 Jun 26 |
| Dividend per share | n/a |
| Payout ratio | 21% |
Recent dividend and buyback updates
Recent updates
New Narrative • May 07
Agentic AI And Non FTE Models Will Shape Balanced Long Term Outcomes
Catalysts About Genpact Genpact provides business process and technology services, with a focus on data, AI and agentic solutions that help large enterprises run core operations. What are the underlying business or industry changes driving this perspective?
Narrative Update • Apr 23
G: AI Partnership And Expanded Capital Returns Will Support Future Shareholder Value
Analysts have trimmed their price target on Genpact slightly to about $48.18 from roughly $48.64, reflecting updated assumptions around discount rate, revenue growth, profit margin and future P/E that remain largely in line with prior views. What's in the News Genpact announced a partnership with Parallel Web Systems to use Parallel's AI native web agents and search tools, delivered via APIs, to support information search, retrieval, and web intelligence across its business operations, including use cases in insurance and sales.Narrative Update • Apr 09
G: AI Partnership And Capital Returns Will Support Stronger Future Shareholder Value
Analysts kept their fair value estimate for Genpact steady at about $48.64, citing only small model tweaks in the discount rate, revenue growth, profit margin, and future P/E assumptions that did not materially alter their price target view. What's in the News Genpact entered a partnership with Parallel Web Systems to use Parallel's AI native web agents and web search tools via API, aiming to improve information search, retrieval, and web intelligence across business operations, including insurance claims and sales use cases (Key Developments).Narrative Update • Mar 25
G: Buybacks And Higher Dividend Will Drive Stronger Future Shareholder Returns
Analysts now hold Genpact's fair value steady at $48.64, with only small tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E used to support their unchanged price target view. What's in the News From October 1, 2025 to February 25, 2026, Genpact repurchased 3,415,026 shares, representing 1.98% of its share count, for $145.95m under its ongoing buyback program.Narrative Update • Mar 11
G: Buybacks And Higher Dividend Will Support Attractive Future Shareholder Returns
Analysts have maintained their $48.64 price target on Genpact. They have made small adjustments to assumptions such as the discount rate, revenue growth, profit margin, and future P/E ratio, which refine rather than change their overall view.Narrative Update • Feb 25
G: Buybacks And Higher Dividend Will Support Attractive Long Term Returns
Analysts have trimmed their price target for Genpact by a small amount to $48.64 from $48.82, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E estimates. What's in the News Genpact issued earnings guidance for the first quarter of 2026, with net revenues projected between US$1.282b and US$1.294b and diluted EPS in the US$0.79 to US$0.80 range (company guidance).Seeking Alpha • Feb 17
Genpact Limited: Strategic Transformation Driving Strong Performance And Valuation Upside
Summary Genpact Limited is significantly undervalued, trading at 30-40% discounts to sector and historical multiples despite stable results and strategic transformation. Q4 results exceeded expectations: revenue was up 5.6% YoY, the Advanced Technology Solutions segment grew 15% YoY, and gross margin improved by 90 bps to 36.6%. Management’s shift to higher-margin, technology-driven, non-FTE contracts is driving margin expansion and recurring revenue, with 46% of revenue now in the new format. My DCF and multiples analysis yield a $43 target price (15% upside); I assign a Buy rating, supported by conservative forecasts and healthy debt metrics. Read the full article on Seeking AlphaAnalysis Article • Feb 09
Genpact (NYSE:G) Is Increasing Its Dividend To $0.1875
Genpact Limited's ( NYSE:G ) dividend will be increasing from last year's payment of the same period to $0.1875 on 31st...Narrative Update • Feb 07
G: Buybacks And Rising Dividends Will Support Steady Long Term Outcomes
Analysts have trimmed their price target for Genpact from about US$50.91 to roughly US$48.82, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E levels. What's in the News Genpact reported that from October 1, 2025 to December 31, 2025, it repurchased 2,080,761 shares, representing 1.21% of shares, for US$100.06m under its ongoing buyback program.Narrative Update • Jan 10
G: AI Services And Buybacks Will Support Steady Long Term Outcomes
Analysts have nudged their price target on Genpact higher to about US$50.91 from roughly US$50.36, citing updated assumptions around revenue growth, profit margins, and future P/E levels. What's in the News Genpact updated full year 2025 guidance, now expecting net revenues of US$5.059b to US$5.071b, which the company describes as approximately 6.1% to 6.4% year over year as reported and 5.9% to 6.2% on a constant currency basis, compared with prior guidance of approximately 4.0% to 6.0% as reported (company guidance).Narrative Update • Dec 25
G: AI Services And Buybacks Will Support Balanced Long Term Performance
Analysts have nudged their price target for Genpact slightly higher to approximately 50.36 dollars from about 50.20 dollars, citing modestly improved long term growth and valuation assumptions, despite a small downward revision to profit margin forecasts. What's in the News Genpact reported that between July 1 and September 30, 2025, it repurchased 2,021,229 shares for about 89.99 million dollars, bringing total buybacks under its long running program to 68,817,622 shares, or 35.4 percent of shares outstanding, for roughly 2.29 billion dollars (company buyback update).Narrative Update • Dec 11
G: AI Insurance Workflow Suite And Buybacks Will Support Steady Future Performance
Analysts have modestly raised their price target on Genpact to $50.20, citing slight improvements in discount rate assumptions and forward valuation metrics while maintaining a stable fair value outlook. What's in the News Completed a major share repurchase tranche, buying back 2,021,229 shares in the latest quarter and reaching a cumulative 35.4% of shares repurchased under the multi year program announced in 2015 (company filing) Raised full year 2025 revenue guidance to $5.059 billion to $5.071 billion, implying 6.1% to 6.4% year over year growth as reported, with stronger outlooks for both Data Tech AI and Digital Operations segments (company guidance) Guided fourth quarter 2025 revenues to $1.298 billion to $1.311 billion, targeting 4.0% to 5.0% reported growth and diluted EPS of $0.78 to $0.80 (company guidance) Launched the Genpact Insurance Policy Suite for commercial and specialty insurance, an AI driven workflow offering built on Microsoft Azure and aimed at achieving up to 90% touchless submission clearance and significantly lower operating costs for insurers (product announcement) Valuation Changes Fair Value Estimate is unchanged at $50.20 per share, reflecting a stable fundamental outlook.Narrative Update • Nov 26
G: AI Will Drive Efficiency With Lower Costs In Insurance Workflows
Analysts have slightly lowered their price target for Genpact from $50.30 to $50.20. They cited modestly improved revenue growth and profit margin forecasts, balanced by a decrease in future price-to-earnings expectations.Analysis Article • Nov 12
Genpact Limited Just Beat EPS By 8.0%: Here's What Analysts Think Will Happen Next
Genpact Limited ( NYSE:G ) investors will be delighted, with the company turning in some strong numbers with its latest...Narrative Update • Nov 07
G: Insurance AI Workflows Will Drive Efficiency and Cost Reduction
Analysts have maintained Genpact's fair value estimate at $50.30. They cite steady expectations for future growth and margins, despite a slight uptick in the discount rate and projected price-to-earnings ratio.Narrative Update • Oct 24
AI Solutions And Buybacks Will Shape Future Service Transformation
Analysts have lowered their price target for Genpact from $52.44 to $50.30, citing modest reductions in projected revenue growth and profit margin expectations. What's in the News Genpact launched the Genpact Insurance Policy Suite, an AI-powered workflow solution for commercial and specialty insurance.Analysis Article • Aug 06
Is It Time To Consider Buying Genpact Limited (NYSE:G)?
NYSE:G 1 Year Share Price vs Fair Value Explore Genpact's Fair Values from the Community and select yours Genpact...Analysis Article • Jul 16
Benign Growth For Genpact Limited (NYSE:G) Underpins Its Share Price
With a price-to-earnings (or "P/E") ratio of 14.6x Genpact Limited ( NYSE:G ) may be sending bullish signals at the...Analysis Article • Jul 03
Is Genpact (NYSE:G) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Jun 19
Is There An Opportunity With Genpact Limited's (NYSE:G) 44% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Genpact fair value estimate is US$75.14 Current share price of...Analysis Article • May 10
Earnings Beat: Genpact Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
It's been a sad week for Genpact Limited ( NYSE:G ), who've watched their investment drop 15% to US$42.46 in the week...Seeking Alpha • Feb 23
Genpact: AI Explosion Exposure, But Not That Cheap Anymore (Rating Downgrade)
Summary Genpact's diverse client base and exposure to high-growth markets like AI and digital transformation have driven significant revenue and free cash flow growth. The company's proprietary AI platform, Genpact Cora, enhances customer experience and accelerates digital transformation, contributing to its solid financial performance. Recent dividend increases and a $500 million stock repurchase program indicate strong shareholder returns, potentially boosting future stock demand. Despite positive financials, the stock's current valuation limits upside potential, leading me to close my position due to decreased margin of safety. Read the full article on Seeking AlphaSeeking Alpha • Jan 05
Genpact Limited: The Overlooked Value Stock In Digital Transformation
Summary Genpact Limited (G) is a value investment with strong fundamentals, including consistent revenue growth, stable margins, and a conservative balance sheet. G's leadership in digital transformation and business process outsourcing, along with a diverse client base, supports its long-term investment potential. Macro factors like global economic conditions, inflation, and currency exchange rates can impact G's performance, but its operational efficiencies and recurring revenue model provide stability. G's intrinsic valuation suggests significant upside, with a target price of ~$61 per share, making it a compelling buy-and-hold opportunity. Read the full article on Seeking AlphaSeeking Alpha • Dec 16
Genpact: Steady Performer But Wait For A Wider Margin Of Safety
Summary Genpact's stock appreciated 25.83% since February 2024, outperforming the S&P 500, but the current price offers only a 5.41% margin of safety. Under new CEO Balkrishan Kalra, Genpact's 3+1 Execution Framework has driven significant revenue and earnings growth, particularly through Data-Tech-AI initiatives. The company raised its revenue and earnings guidance three times in 2024, reflecting strong performance and increased client engagement through strategic partnerships. Despite an improved fair value of $47.09, the current price of $44.67 suggests holding shares rather than buying due to a smaller margin of safety. Read the full article on Seeking AlphaUpcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, G has been paying a dividend for less than 10 years.
Growing Dividend: G's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividend Yield vs Market
| Genpact Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (G) | 2.2% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Professional Services) | 2.6% |
| Analyst forecast (G) (up to 3 years) | 2.4% |
Notable Dividend: G's dividend (2.18%) is higher than the bottom 25% of dividend payers in the US market (1.39%).
High Dividend: G's dividend (2.18%) is low compared to the top 25% of dividend payers in the US market (4.21%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (21.4%), G's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (17.6%), G's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/07 15:07 |
| End of Day Share Price | 2026/05/07 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Genpact Limited is covered by 23 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Koning | Baird |
| Keith Bachman | BMO Capital Markets Equity Research |
| Kunal Tayal | BofA Global Research |